Merited Wealth’s Organon & Co OGN Stock Holding History

Merited Wealth’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-24	Closed	-$172	–	222
2025 Q4	$172	Buy	+24	New	+$190	﹤0.01%	297

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

KBG

Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Merited Wealth's OGN Position: Q1 2026 in Review

Merited Wealth sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 24 shares — an estimated $172 sold.

Merited Wealth first reported a position in OGN in Q4 2025 and held it in 1 quarter. The position peaked at $172 in Q4 2025. 607 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

Merited Wealth reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
Merited Wealth sold 24 Organon & Co shares in Q1 2026, an estimated $172.
Merited Wealth first reported a position in Organon & Co in Q4 2025 and held it in 1 quarter.
Merited Wealth's Organon & Co position peaked at $172 in Q4 2025.
607 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Merited Wealth's 13F filing for Q1 2026, filed 24 Apr 2026.